Job Watch

Request for Information (RFI): Input on NIH Tickborne Diseases Strategic Plan

Notice NOT-OD-19-077 from the NIH Guide for Grants and Contracts

Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional)

Funding Opportunity RFA-FD-19-003 from the NIH Guide for Grants and Contracts. The Food and Drug Administration (FDA)/ Center for Food and Safety and Applied Nutrition (CFSAN) is announcing its intention to receive and consider a single source application for the award of a cooperative agreement in fiscal year 2019 to the Illinois Institute of Technology to support the Institute for Food Safety and Health (IFSH). The purposes of this continued support are to: 1. Carry out multidisciplinary applied research projects on the safety of processed foods; on food processing and packaging technologies; on the impact of these processing strategies on the nutritional quality of food; and on laboratory method performance (including method validation) that address issues associated with FDA-regulated products and that are consistent with CFSAN's Science and Research Strategic Plan; 2. Maintain and facilitate the further development of the IFSH collaborative research program by leveraging resources among U.S. government agencies, universities (including other IIT components), and the food industry to achieve practical solutions to food safety and food processing issues; 3. Develop and implement outreach and communication programs with stakeholders to identify research needs and to facilitate the use of the information produced by the research program; and 4. Support the implementation of the FDA Food Safety Modernization Act through research, education, and outreach, with particular emphasis on the science behind preventive controls associated with manufacturing, processing, packing and holding of food.

Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-185 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHGRI R25 program is to support educational activities that support advanced level courses that are intended to disseminate new knowledge, techniques, methods, and analyses related to the mission of the NHGRI. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.

Wellcome Sanger Institute: Statistical Geneticist

New Scientist - Bioinformatics - Fri, 2019-02-08 13:27
£36,000-£44,000 per annum depending on experience plus excellent benefits: Wellcome Sanger Institute: Job Reference 83297 Statistical Geneticist Salary range: £36,000-£44,000 per annum depending on experience plus excellent benefits. Fixed Term Hinxton, Cambridgeshire, England
Categories: Job Watch

Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-ES-19-001 from the NIH Guide for Grants and Contracts. Chemical modifications of protein, DNA and RNA nucleoside moieties play critical roles in regulating gene expression. Emerging evidence suggests RNA modifications have substantive roles in multiple basic biological processes. Epitranscriptomics can be defined as the aggregate suite of functional biochemical modifications to the transcriptome within a cell. Recent studies in yeast, Drosophila, rodent and human models demonstrate that stressors can induce RNA modifications, with specific reprogramming of some regulatory RNAs. The NIEHS seeks to solicit innovative, mechanistic research applications that are focused on how environmental exposures are associated and involved with the functional activities of RNA modifications and pathways that may be modified or misregulated, associated with adverse health outcomes and/or be useful as biomarkers of exposure and/or exposure-induced pathologies. The study of functional chemical RNA modification has identified important emerging roles in cellular regulation and gene expression. However, the impact of environmental exposures on functional RNA modifications has been relatively understudied and may present a new mechanism for enhanced understanding the relationships between exposures and the development of complex human diseases. The NIEHS will use the R01 mechanism to support hypothesis driven research using approaches that incorporate principles of toxicology with RNA modification biological and/or chemical expertise and utilizes state of the art technologies.

Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-ES-19-002 from the NIH Guide for Grants and Contracts. Chemical modifications of proteins, DNA and RNA nucleoside moieties play critical roles in regulating gene expression. Emerging evidence suggests these RNA modifications (epitranscriptomics) have substantive roles in basic biological processes. Recent studies in yeast, Drosophila and rodent models demonstrate stressors can induce RNA modifications, with specific epitranscriptomic reprogramming of some regulatory RNAs. The purpose of the eFRAMED FOA is to solicit and support R21 applications that propose conducting innovative, high risk, high reward research to enhance our understanding of how environmental exposures impact this layer of cellular regulation.

Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-19-012 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support a national network of research centers for development of effective and comprehensive medical countermeasures applicable to all subsets of the civilian population in the event of radiological or nuclear emergencies. Applications are sought that propose multidisciplinary basic and translational research to support the development of new medical products that will assess, diagnose, mitigate and/or treat the short-, delayed- and long-term consequences of radiation exposure during and following a radiation public health emergency (e.g. a radiological/nuclear terrorist incident or accident). The goals of this FOA are to: 1) develop new techniques and devices to measure radiation exposure in the human body; 2) follow biomarkers of tissue damage and recovery; and 3) further develop existing (e.g. products in clinical use) as well as novel therapies to minimize tissue damage, hasten tissue recovery, restore normal physiological function, and improve survival.

Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)

Funding Opportunity RFA-ES-19-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Phase I (R43) and Fast-track (R44) Small Business Innovative Research (SBIR) grant applications from small business concerns (SBCs) in collaboration with environmental science researchers to develop novel tools, activities, or materials to build environmental health literacy for a variety of groups, including community members, health care and public health professionals, educators, and students of all ages.

Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)

Funding Opportunity RFA-ES-19-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Phase I (R43) and Fast-track (R44) Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) in collaboration with environmental science researchers to develop novel tools, activities, or materials to build environmental health literacy for a variety of groups, including community members, health care and public health professionals, educators, and students of all ages.

Pages

Subscribe to Anil Jegga aggregator - Job Watch